De Kock M, Versailles H, Colinet B, Karthaeuser R, Scholtes J L
Department of Anesthesiology, University of Louvain Medical School, St. Luc Hospital, Brussels, Belgium.
J Clin Anesth. 1995 Aug;7(5):403-10. doi: 10.1016/0952-8180(95)00072-p.
Determine the hemodynamic consequences of intraoperative clonidine during major abdominal surgery.
Prospective open trial.
Teaching hospital.
402 consecutive patients scheduled for major abdominal surgery.
350 consecutive patients received intravenous (IV) clonidine (loading dose of 4 micrograms/kg in 20 minutes at anesthesia induction, followed by a continuous infusion of 2 micrograms/kg/h until the end of surgery). Fifty-two additional patients served as controls. Anesthetic technique consisted of balanced anesthesia (isoflurane, fentanyl, atracurium). ECG, invasive arterial blood pressure (BP), expiratory PCO2 and pulse oximetry were continuously recorded. Hemodynamic events (HEs) were defined as moderate for a 20% reduction of the baseline systolic blood pressure (SBP) or a heart rate (HR) decreasing between 50 beats per minute (bpm) and 40 bpm. A 30% reduction of the baseline SBP or a HR below 40 bpm was considered an important HE. The rate and duration of these events were recorded from induction to recovery. HEs requiring a specific treatment were noted. Central venous pressure, volume of fluid infused, and urinary output were also recorded.
21% of control patients and 31% of clonidine patients had no adverse HEs. A moderate reduction of the baseline BP was the most common episode in both groups. The incidence of the HEs (moderate and important) was similar in both groups but the duration HEs was significantly longer in the clonidine patients (p < 0.05). 40% of the control patients and 13% of the clonidine patients required specific management for their HEs (p < 0.05), the most common of which was hypotension without bradycardia. Neither coexisting pathology nor preoperative medications influenced the incidence of HEs.
IV clonidine can be used routinely during anesthesia for major abdominal surgery.
确定腹部大手术中使用可乐定的血流动力学影响。
前瞻性开放试验。
教学医院。
402例连续安排进行腹部大手术的患者。
350例连续患者接受静脉注射可乐定(麻醉诱导时20分钟内负荷剂量为4微克/千克,随后持续输注2微克/千克/小时直至手术结束)。另外52例患者作为对照。麻醉技术包括平衡麻醉(异氟烷、芬太尼、阿曲库铵)。持续记录心电图、有创动脉血压(BP)、呼气末二氧化碳分压和脉搏血氧饱和度。血流动力学事件(HEs)定义为基线收缩压(SBP)降低20%或心率(HR)降至每分钟50次(bpm)至40次bpm之间为中度。基线SBP降低30%或HR低于40 bpm被视为重要的HE。记录这些事件从诱导到恢复的发生率和持续时间。记录需要特殊治疗的HEs。还记录中心静脉压、输注液体量和尿量。
21%的对照患者和31%的可乐定患者无不良HEs。两组中最常见的情况是基线血压适度降低。两组中HEs(中度和重度)的发生率相似,但可乐定组的HEs持续时间明显更长(p < 0.05)。40%的对照患者和13%的可乐定患者因其HEs需要特殊处理(p < 0.05),最常见的是无心动过缓的低血压。并存的病理情况和术前用药均未影响HEs的发生率。
腹部大手术麻醉期间可常规使用静脉注射可乐定。